Nan Fung Group Holdings LTD Biomarin Pharmaceutical Inc Transaction History
Nan Fung Group Holdings LTD
- $103 Million
- Q3 2024
A detailed history of Nan Fung Group Holdings LTD transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Nan Fung Group Holdings LTD holds 10,815 shares of BMRN stock, worth $710,112. This represents 0.74% of its overall portfolio holdings.
Number of Shares
10,815
Previous 10,815
-0.0%
Holding current value
$710,112
Previous $890,000
14.61%
% of portfolio
0.74%
Previous 1.04%
Shares
5 transactions
Others Institutions Holding BMRN
# of Institutions
637Shares Held
177MCall Options Held
2.01MPut Options Held
1.28M-
Black Rock Inc. New York, NY22.7MShares$1.49 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.3MShares$1.27 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.9MShares$1.24 Billion0.99% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$913 Million0.59% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.5MShares$689 Million0.16% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.2B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...